← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Atlantic Health System, Inc.
Morristown, NJ
$8,845,596
Total funding
4
Grants
Funding over time
peak $1.1M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,845,596 · 4
By mechanism
UG1$6,106,706 · 1
R01$2,438,790 · 2
R13$300,100 · 1
Investigators at Atlantic Health System, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP)$1,079,764
UG1 · FY2019 · CA
The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP)$973,936
UG1 · FY2020 · CA
The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP)$924,915
UG1 · FY2023 · CA
The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP)$875,580
UG1 · FY2021 · CA
The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP)$870,712
UG1 · FY2022 · CA
The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP)$736,036
UG1 · FY2024 · CA
The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC Corp)$645,763
UG1 · FY2025 · CA
The role of ECE-2 in regulating Abeta levels in Alzheimer's disease$335,043
R01 · FY2010 · NS
The role of ECE-2 in regulating Abeta levels in Alzheimer's disease$318,245
R01 · FY2011 · NS
The role of ECE-2 in regulating Abeta levels in Alzheimer's disease$318,245
R01 · FY2012 · NS
The role of ECE-2 in regulating Abeta levels in Alzheimer's disease$315,062
R01 · FY2014 · NS
The role of ECE-2 in regulating Abeta levels in Alzheimer's disease$307,107
R01 · FY2013 · NS
The neurogenic potential of cholinergic activation in AD.$286,957
R01 · FY2012 · AG
The neurogenic potential of cholinergic activation in AD.$286,957
R01 · FY2011 · AG
The neurogenic potential of cholinergic activation in AD.$271,174
R01 · FY2013 · AG
Neurobiology of Disease in Children Conferences$55,000
R13 · FY2019 · NS
Neurobiology of Disease in Children Conferences$50,000
R13 · FY2015 · NS
Neurobiology of Disease in Children Conferences$50,000
R13 · FY2018 · NS
Neurobiology of Disease in Children Conferences$50,000
R13 · FY2016 · NS
Neurobiology of Disease in Children Conferences$45,000
R13 · FY2020 · NS